NEWS 
Jan 29, 2019
The National Cancer Institute (NCI), through the NCI Technology Transfer Center (TTC), now offers a term-limited, exclusive Start-Up Evaluation Option License to start-up companies developing early-stage vaccine, therapeutic, device, and certain...
Jan 3, 2019
Proposal(s) are sought in response to RFP # NIH-OD-OLAO-OA-(PLS)-2019 for Patent-Legal Services. This solicitation is full and open to ALL capable business concerns in the U.S. The North American Industry Classification System (NAICS) code for this...
Nov 20, 2018
The NIH’s tech transfer community is pursuing new law firm contracts for managing patent prosecution matters as the current contracts end Spring of 2019. As part of the development for the new Request For Proposals (RFP), the community is providing...
New & Updated Opportunities
Feb 12, 2019
Papillomavirus pseudoviruses that comprise the L1/L2 capsid proteins can package a wide variety of non-viral DNA plasmids and deliver the packaged genetic material to...
Feb 9, 2019
Researchers at the National Cancer Institute (NCI) developed novel hydrogel compositions and methods of using them in the microsurgical suturing of blood vessels, which...
Jan 17, 2019
The technology addresses treatment options for diseases such as sickle-cell and thalassemia. Traditionally, such beta-globinopathies are treated through bone marrow...